Aristeia Capital »

Corcept Therapeutics Incorporated shares owned by Aristeia Capital

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Aristeia Capital from 13F filings

Historical chart of Aristeia Capital investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Aristeia Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Aristeia Capital

Quarter filed Position value Share count Share price at filing
2023-03-31 $11M 502k 21.66

More positions owned by Aristeia Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Liberty Broadband Corp Com Ser C (LBRDK)
Carnival Adr (CUK)
Affirm Hldgs Note 11/1 (Principal)
Liberty Media Corp Del Com Lbty Srm S C (LSXMK)
Liberty Broadband Corp Com Ser A (LBRDA)
Liberty Media Corp Del Com Lbty Srm S A (LSXMA)
Guardant Health Note 11/1 (Principal)
Docusign Note 1/1 (Principal)
Screaming Eagle Acquisitn Class A Ord Shs (SCRM)
Dish Network Corporation Note 2.375% 3/1 (Principal)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Wix Note 8/1 (Principal)
Transocean Deb 4.000%12/1 (Principal)
Microstrategy Note 2/1 (Principal)

View all positions for Aristeia Capital

Top funds holding Corcept Therapeutics Incorporated

Vanguard Group
Ingalls & Snyder
Parallel Advisors
Dimensional Fund Advisors
Btim
Federated Investors
D. E. Shaw & Co
Arrowstreet Capital, Limited Partnership
Charles Schwab Investment Management
Man Group
Bank of New York Mellon
Norges Bank Investment Management
Millennium Management
Kynam Capital Management
Citadel Advisors

View all funds holding Corcept Therapeutics Incorporated